Ocular Therapeutix, Inc.
USD10.16
+0.26 (+2.63%)
CEO
Pravin U. Dugel
IPO Date
2014-07-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$9.98
Prev. Close
$9.90
Day Low
$9.86
Day High
$10.18
52W Low
$6.23
52W High
$16.44
Market Cap
$2.22B
Volume
0.73M
| 50,092 |
| $0.00 |
| 12 Jun 2026 | Warden Charles M | director | A-Award | Acquired | 14,000 | $0.00 |
| 12 Jun 2026 | Warden Charles M | director | A-Award | Acquired | 44,000 | $8.74 |
| 12 Jun 2026 | Graves Adrienne L | director | A-Award | Acquired | 14,000 | $0.00 |
| 12 Jun 2026 | Graves Adrienne L | director | A-Award | Acquired | 44,000 | $8.74 |
| 12 Jun 2026 | Robins Jason Shand | Chief Financial Officer | A-Award | Acquired | 15,441 | $0.00 |
| 12 Jun 2026 | Robins Jason Shand | Chief Financial Officer | A-Award | Acquired | 14,024 | $8.74 |
| 12 Jun 2026 | Hong Seung Suh | director | A-Award | Acquired | 14,000 | $0.00 |
| 12 Jun 2026 | Hong Seung Suh | director | A-Award | Acquired | 44,000 | $8.74 |